ArticleMedical oncology (Northwood, London, England)2019

High total bilirubin level is a significant risk factor for severe neutropenia in patients receiving irinotecan-based chemotherapy.

Yunami Yamada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.